Article
Residual cholesterol synthesis and simvastatin induction of cholesterol synthesis in Smith-Lemli-Opitz syndrome fibroblasts.
Molecular genetics and metabolism - 1 Jun 2005
Wassif Christopher A, Krakowiak Patrycja A, Wright Brooke S, Gewandter Jennifer S, Sterner Allison L, Javitt Norman, Yergey Alfred L, Porter Forbes D
Abstract excerpt
Smith-Lemli-Opitz syndrome (RSH/SLOS) is an autosomal recessive, malformation syndrome caused by mutations in the 3beta-hydroxysterol delta7-reductase gene (DHCR7). DHCR7 catalyzes the reduction of 7-dehydrocholesterol (7DHC) to cholesterol. We report the mutation analysis and determination of residual cholesterol synthesis in 47 SLOS patients, and the effects of treatment of SLOS skin fibroblasts with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
